Based on the limited data available so far it looks like Middle East Respiratory Syndrome (MERS) has already taken a toll on Korea’s economy. In this Update, we outline our best and worse case scenarios for how the MERS crisis could unfold, and assess the implications for growth.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services